Biotechnology - Genomic and Proteomics/Open Business models in BGP: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
[[Report April 2009]] | [[Report April 2009]] | ||
{{TOCright}} | {{TOCright}} | ||
==Data== | =Concept of OB== | ||
==Narratives== | [http://publius.cc/what_open_business_really_about/041009 What is Open Business Really About?] | ||
Essay by Carolina Rossini. Berkman Center Publius Project. April 10, 2009 | |||
==OB in Genomic Data== | |||
==OB for Biotechnology Narratives== | |||
Open Access Business Models [[KEI study]] | Open Access Business Models [[KEI study]] | ||
==Tools== | ==OB for Biotechnology Tools== | ||
==Navigation== | ==Navigation== | ||
[[Bibliography for Item 12 in BGP]]<br> | [[Bibliography for Item 12 in BGP]]<br> | ||
[[Biotechnology_-_Genomic_and_Proteomics]] | [[Biotechnology_-_Genomic_and_Proteomics]] |
Revision as of 22:20, 19 April 2010
Concept of OB=
What is Open Business Really About? Essay by Carolina Rossini. Berkman Center Publius Project. April 10, 2009
OB in Genomic Data
OB for Biotechnology Narratives
Open Access Business Models KEI study
OB for Biotechnology Tools
Bibliography for Item 12 in BGP
Biotechnology_-_Genomic_and_Proteomics